Moreover, it has been shown that liraglutide, a glucagon-like peptide-1 (GLP-1) derivative originally developed for the treatment of type 2 diabetes, has a neuroprotective effect by rescuing HFD-induced microgliosis in the ARC of mice [42]. This evidence concerns the gene GCG and type 2 diabetes mellitus.